OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
18
Results
Show all
Save search
Copy query
Show results for
Unknown
(16)
Models
(2)
Repository
BioModels
(2)
Publication Date
2019
(2)
IsPrivate
False
(2)
Release Date
2021
(4)
2022
(3)
2024
(2)
2023
(2)
2011
(2)
2025
(1)
2016
(1)
2013
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With Cancer.
Not available
S-EPMC5321104
|
biostudies-literature
Cite
Postbariatric hypoglycemia: symptom patterns and associated risk factors in the Longitudinal Assessment of Bariatric Surgery study.
Not available
S-EPMC9944569
|
biostudies-literature
Cite
Cardiomyocyte Telomere Damage
No description
2019-02-14
|
MODEL1608250000
|
BioModels
Cite
Cardiomyocyte Telomere Damage by ROS without Cell Division
No description
2019-02-14
|
MODEL1608250001
|
BioModels
Cite
Stratified analyses refine association between TLR7 rare variants and severe COVID-19.
Not available
S-EPMC11320601
|
biostudies-literature
Cite
Results of the two incidence screenings in the National Lung Screening Trial.
Not available
S-EPMC4307922
|
biostudies-literature
Cite
Reduced lung-cancer mortality with low-dose computed tomographic screening.
Not available
S-EPMC4356534
|
biostudies-literature
Cite
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998
|
biostudies-literature
Cite
The National Lung Screening Trial: overview and study design.
Not available
S-EPMC3009383
|
biostudies-literature
Cite
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC11872607
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets